The Associated PressNEW YORK (AP) ¿ The following stocks were among those that moved substantially or traded heavily Tuesday on the New York Stock Exchange: NYSE: CIT Group Inc., down 11 cents at 96 cents Billionaire investor Carl Icahn offered to buy certain classes of debt to thwart a restructuring plan by the commercial lender. Patriot Coal Corp., up $1.59 at $12.78 The St. Louis company said it's the latest U.S. producer to benefit from resurgent demand for metallurgical coal. WMS Industries Inc., down $4.37 at $43.03 The casino equipment maker's revenue missed analysts' expectations, while it provided a disappointing second-quarter outlook. Carter's Inc., down $6.78 at $21.66 The children's clothing maker delayed reporting third-quarter results while it reviews its accounting regarding wholesale customers. United States Steel Corp., down $3.17 at $37.41 U.S. Steel lost money for a third straight quarter as the global economic downturn dragged down demand for the metal. NASDAQ: Lululemon Athletica Inc., up $2.19 at $27.90 The athletic apparel maker raised its third-quarter profit and revenue forecasts, citing stronger than expected sales. Scientific Games Corp., down $3.85 at $13.85 News of the planned retirement of CEO Joseph Wright came as the gaming equipment supplier also reported a third-quarter profit decline. PrivateBancorp Inc., down $2.33 at $9.65 The community bank said its loss widened as a result of its deteriorating credit portfolio, especially its commercial real estate.
More from Investing
Top 5 Stock Winners in Dow Jones Industrial Average This Week
The Dow Jones Industrial Average finished Friday above 28000 for the first time ever. Here are the top 5 winning stocks in the Dow from this week.
Why Stock Charts Are a More Valuable Tool Than Ever
What I have found is that the real value of charts is as a trade management tool.
Novartis Still a Buy Despite Controversy Over Blockbuster Drug
Despite the issues that have bubbled up related to its breakthrough drug for spinal muscular atrophy, Zolgensma, Novartis "has the newest pipeline with many drugs just beginning to have an impact on the company's bottom line," Cramer told members of his Action Alerts PLUS club for investors during an exclusive video-conference call.